Publications | PubMed=3335022 Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48:589-601(1988) PubMed=1958593; DOI=10.1002/gcc.2870030406 Bradford C.R., Kimmel K.A., Van Dyke D.L., Worsham M.J., Tilley B.J., Burk D., del Rosario F., Lutz S., Tooley R., Hayashida D.J.S., Carey T.E. 11p deletions and breakpoints in squamous cell carcinoma: association with altered reactivity with the UM-E7 antibody. Genes Chromosomes Cancer 3:272-282(1991) DOI=10.1016/B978-0-12-333530-2.50007-1 Carey T.E. Head and neck tumor cell lines. (In book chapter) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.79-120; Academic Press; New York; USA (1994) PubMed=8679156; DOI=10.1007/BF00178278 Koldovsky P., Haas I., Bier H., Ganzer U. Immunohistochemical examination of 11 cell lines derived from human head and neck squamous cell carcinomas, their recurrences or metastases. Eur. Arch. Otorhinolaryngol. 252:359-365(1995) PubMed=9139877; DOI=10.1002/(SICI)1097-0215(19970502)71:3<410::AID-IJC18>3.0.CO;2-J Welters M.J.P., Fichtinger-Schepman A.M.J., Baan R.A., Hermsen M.A.J.A., van der Vijgh W.J.F., Cloos J., Braakhuis B.J.M. Relationship between the parameters cellular differentiation, doubling time and platinum accumulation and cisplatin sensitivity in a panel of head and neck cancer cell lines. Int. J. Cancer 71:410-415(1997) PubMed=10956384; DOI=10.1002/1097-0215(20000915)87:6<771::AID-IJC2>3.0.CO;2-V Backus H.H.J., Pinedo H.M., Wouters D., Padron J.M., Molders N., van der Wilt C.L., van Groeningen C.J., Jansen G., Peters G.J. Folate depletion increases sensitivity of solid tumor cell lines to 5-fluorouracil and antifolates. Int. J. Cancer 87:771-778(2000) PubMed=15287027; DOI=10.1002/gcc.20066 Takebayashi S., Hickson A., Ogawa T., Jung K.-Y., Mineta H., Ueda Y., Grenman R., Fisher S.G., Carey T.E. Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer. Genes Chromosomes Cancer 41:145-154(2004) PubMed=15495191; DOI=10.1002/gcc.20119 Raschke S., Balz V., Efferth T., Schulz W.A., Florl A.R. Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines. Genes Chromosomes Cancer 42:58-67(2005) PubMed=16203773; DOI=10.1158/1078-0432.CCR-05-0378 Mandic R., Schamberger C.J., Muller J.F., Geyer M., Zhu L., Carey T.E., Grenman R., Dunne A.A., Werner J.A. Reduced cisplatin sensitivity of head and neck squamous cell carcinoma cell lines correlates with mutations affecting the COOH-terminal nuclear localization signal of p53. Clin. Cancer Res. 11:6845-6852(2005) PubMed=17312569; DOI=10.1002/hed.20478 Lin C.J., Grandis J.R., Carey T.E., Gollin S.M., Whiteside T.L., Koch W.M., Ferris R.L., Lai S.Y. Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head Neck 29:163-188(2007) PubMed=18006756; DOI=10.1158/1078-0432.CCR-07-1591 Friedman J., Nottingham L.K., Duggal P., Pernas F.G., Yan B., Yang X.-P., Chen Z., Van Waes C. Deficient TP53 expression, function, and cisplatin sensitivity are restored by quinacrine in head and neck cancer. Clin. Cancer Res. 13:6568-6578(2007) PubMed=18487078; DOI=10.1016/j.oraloncology.2008.02.006 Hoffmann T.K., Sonkoly E., Hauser U., van Lierop A., Whiteside T.L., Klussmann J.P., Hafner D., Schuler P.J., Friebe-Hoffmann U., Scheckenbach K., Erjala K., Grenman R., Schipper J., Bier H., Balz V. Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma. Oral Oncol. 44:1100-1109(2008) PubMed=19760794; DOI=10.1002/hed.21198; PMCID=PMC3292176 Brenner J.C., Graham M.P., Kumar B., Saunders L.M., Kupfer R., Lyons R.H., Bradford C.R., Carey T.E. Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines. Head Neck 32:417-426(2010) PubMed=20145189; DOI=10.1158/1940-6207.CAPR-09-0076; PMCID=PMC2833226 Chakravarti N., Kadara H., Yoon D.-J., Shay J.W., Myers J.N., Lotan D., Sonenberg N., Lotan R. Differential inhibition of protein translation machinery by curcumin in normal, immortalized, and malignant oral epithelial cells. Cancer Prev. Res. (Philadelphia) 3:331-338(2010) PubMed=20947470; DOI=10.1186/2047-783X-15-8-337; PMCID=PMC3458702 Schuler P.J., Trellakis S., Greve J., Bas M.B., Bergmann C., Bolke E., Lehnerdt G.F., Mattheis S., Albers A.E., Brandau S., Lang S.K., Whiteside T.L., Bier H., Hoffmann T.K. In vitro chemosensitivity of head and neck cancer cell lines. Eur. J. Med. Res. 15:337-344(2010) PubMed=21868764; DOI=10.1158/1078-0432.CCR-11-0690; PMCID=PMC3229662 Zhao M., Sano D., Pickering C.R., Jasser S.A., Henderson Y.C., Clayman G.L., Sturgis E.M., Ow T.J., Lotan R., Carey T.E., Sacks P.G., Grandis J.R., Sidransky D., Heldin N.-E., Myers J.N. Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites. Clin. Cancer Res. 17:7248-7264(2011) PubMed=23613873; DOI=10.1371/journal.pone.0061555; PMCID=PMC3629194 Martens-de Kemp S.R., Dalm S.U., Wijnolts F.M.J., Brink A., Honeywell R.J., Peters G.J., Braakhuis B.J.M., Brakenhoff R.H. DNA-bound platinum is the major determinant of cisplatin sensitivity in head and neck squamous carcinoma cells. PLoS ONE 8:E61555-E61555(2013) PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076 Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P., Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B., Liang H. Characterization of human cancer cell lines by reverse-phase protein arrays. Cancer Cell 31:225-239(2017) PubMed=29156801; DOI=10.18632/oncotarget.21174; PMCID=PMC5689691 Kalu N.N., Mazumdar T., Peng S.-H., Shen L., Sambandam V., Rao X.-Y., Xi Y.-X., Li L.-R., Qi Y., Gleber-Netto F.O., Patel A., Wang J., Frederick M.J., Myers J.N., Pickering C.R., Johnson F.M. Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines. Oncotarget 8:86369-86383(2017) PubMed=29873307; DOI=10.1088/1361-6560/aacaba Fru L.C., Adamson E.B., Campos D.D., Fain S.B., Jacques S.L., van der Kogel A.J., Nickel K.P., Song C., Kimple R.J., Kissick M.W. Corrigendum: Potential role of the glycolytic oscillator in acute hypoxia in tumors (2015 Phys. Med. Biol. 60 9215). Phys. Med. Biol. 63:139501-139501(2018) PubMed=31541927; DOI=10.1016/j.oraloncology.2019.09.004; PMCID=PMC7372097 van Harten A.M., Poell J.B., Buijze M., Brink A., Wells S.I., Leemans C.R., Wolthuis R.M.F., Brakenhoff R.H. Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass. Oral Oncol. 98:53-61(2019) |